Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2019 from OUS - Department of Urology
12 publications found
Infectious Complications After Laser Vaporization of Urinary Stones During Retrograde Intrarenal Surgery Are Not Associated with Spreading of Bacteria into Irrigation Fluid but with Previous Use of Fluoroquinolones
Eur Urol Focus (in press)
DOI 10.1016/j.euf.2019.02.018, PubMed 30853604
Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
Int J Mol Sci, 20 (15)
DOI 10.3390/ijms20153833, PubMed 31390729
Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study
Future Microbiol, 14, 1013-1021
DOI 10.2217/fmb-2019-0145, PubMed 31469009
Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis
J Urol, 203 (3), 570-578
DOI 10.1097/JU.0000000000000620, PubMed 31651226
Metagenomics in diagnosis and improved targeted treatment of UTI
World J Urol, 38 (1), 35-43
DOI 10.1007/s00345-019-02731-9, PubMed 30944967
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Eur Urol Oncol, 3 (3), 382-389
DOI 10.1016/j.euo.2019.08.002, PubMed 31506250
Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
World J Urol, 38 (1), 17-26
DOI 10.1007/s00345-019-02837-0, PubMed 31183524
Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
Eur Radiol, 30 (3), 1664-1670
DOI 10.1007/s00330-019-06521-0, PubMed 31748856
MRI in the Follow-up of Testicular Cancer: Less is More
Anticancer Res, 39 (6), 2963-2968
DOI 10.21873/anticanres.13427, PubMed 31177136
Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study
PLoS One, 14 (4), e0214710
DOI 10.1371/journal.pone.0214710, PubMed 31022187
Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
World J Urol, 38 (1), 27-34
DOI 10.1007/s00345-019-02963-9, PubMed 31555835
Potent and specific MTH1 inhibitors targeting gastric cancer
Cell Death Dis, 10 (6), 434
DOI 10.1038/s41419-019-1665-3, PubMed 31164636